Presentation is loading. Please wait.

Presentation is loading. Please wait.

Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy’s Law and a New Prognostic Model  Vincent Lo Re, Kevin Haynes,

Similar presentations


Presentation on theme: "Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy’s Law and a New Prognostic Model  Vincent Lo Re, Kevin Haynes,"— Presentation transcript:

1 Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy’s Law and a New Prognostic Model  Vincent Lo Re, Kevin Haynes, Kimberly A. Forde, David S. Goldberg, James D. Lewis, Dena M. Carbonari, Kimberly B.F. Leidl, K. Rajender Reddy, Melissa S. Nezamzadeh, Jason Roy, Daohang Sha, Amy R. Marks, Jolanda De Boer, Jennifer L. Schneider, Brian L. Strom, Douglas A. Corley  Clinical Gastroenterology and Hepatology  Volume 13, Issue 13, Pages (December 2015) DOI: /j.cgh Copyright © 2015 AGA Institute Terms and Conditions

2 Figure 1 Selection of patients in the study. anti-HBc, hepatitis B core antibody; anti-HCV, hepatitis C virus antibody; anti-HDV, hepatitis D virus antibody; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; HDV, hepatitis D virus; IgM, immunoglobulin. *ICD-9 codes or †Index date = first qualifying date of drug-induced liver injury. ‡Patients may have had more than 1 exclusionary diagnosis recorded. §The upper limits of normal of alanine and aspartate aminotransferase were determined by the assay from which each result was measured. Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh ) Copyright © 2015 AGA Institute Terms and Conditions


Download ppt "Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy’s Law and a New Prognostic Model  Vincent Lo Re, Kevin Haynes,"

Similar presentations


Ads by Google